Gene Therapy Safety Issues Reflect Pushing Of The Scientific Envelope – FDA’s Marks

 
• By Sue Sutter
Speed bump
CBER director Peter Marks believes recent safety issues with gene therapy products are merely speed bumps and overcoming them will advance the science. • Source: Alamy

More from Cell & Gene Therapies

More from Advanced Technologies